Active · per the CBE, 16 September 2026

QBIC Venture Partners

BE0846494353

Rechtspersoon Private limited company 1 establishment

Ottergemsesteenweg-Zuid 808 box 328, 9000 Gent

Behind the company: Danny Gonnissen BV, Loxus BV, Methexis Genomics NV, Innoconsult BV+1.

Active for

14 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    51 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

QBIC Venture Partners from Gent, company number BE0846494353, closed financial year 2025 with a result of € 9,301 after tax. For that financial year QBIC Venture Partners recorded a gross margin of € 13,589 and equity of € 22,649. Compared with financial year 2024, the result moved from € -3,729 to € 9,301. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 23, 2026.

What it is worth Growing

€ 22,649

▲ 70% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 9,301

▲ still € 3,729 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,715

▲ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 16,325.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,535

▼ 75% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,386

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 11,057 € 11,200 € -2,536 € 13,589 ▲ € 16,125
Profit after taxes € 7,902 € 6,941 € -3,729 € 9,301 ▲ € 13,030
Equity € 10,135 € 17,076 € 13,348 € 22,649 ▲ 70%
Total debts € 8,056 € 10,564 € 18,343 € 7,921 ▼ 57%
Cash € 8,675 € 10,936 € 6,402 € 8,715 ▲ 36%
Retained profit € 3,811 € 10,752 € 7,024 € 16,325 ▲ 132%
Balance sheet total € 18,191 € 27,640 € 31,691 € 30,570 ▼ 4%

Key figures of QBIC Venture Partners, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to QBIC Venture Partners?

What happened at QBIC Venture Partners in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 9,301. Source: NBB ↗
  • New establishment in Gent. KBO
  • Start of the company according to the CBE. KBO

In short

From € 7,902 profit in 2022 to € 9,301 profit in 2025.

Paid € 7,898 in corporate taxes since 2022.

Best year ever: 2025, with € 9,301 profit.

Management

Behind QBIC Venture Partners are Danny Gonnissen BV, Loxus BV, Methexis Genomics NV, Innoconsult BV and Sophie Manigart. Danny Gonnissen BV is also behind Newton Biocapital I Investment Pool and Newton Biocapital II Partners. Methexis Genomics NV is also behind QBIC Partners. Innoconsult BV is also behind EVS BROADCAST EQUIPMENT, Faktion and VENTURE SPIRIT.

See the full network in the app

Directors

According to the 2025 annual accounts

Danny Gonnissen BV

Director · represented by Danny Gonnissen

Also active at: Newton Biocapital I Investment Pool, Newton Biocapital II Partners

Loxus BV

Director · represented by Guy Huylebroeck

Methexis Genomics NV

Director · represented by Marc Zabeau

Also active at: QBIC Partners

Innoconsult BV

Director · represented by Martin De Prycker

Also active at: EVS BROADCAST EQUIPMENT, Faktion, VENTURE SPIRIT

Establishments

Establishment units

Physical locations of this company

Registered office

Ottergemsesteenweg-Zuid 808 box 328

9000 Gent

2.212.511.996

Gaston Crommenlaan 10 box 102

9050 Gent

Active since 23 May 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0846.494.353
VAT number
BE 0846.494.353
Registered office
Ottergemsesteenweg-Zuid 808 bus 328, 9000 Gent
Names & denominations
QBIC Venture Partners
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 May 2012
Peppol
Active · Active since 10 Dec 2025

Frequently asked questions

What is the address of QBIC Venture Partners?
The registered office of QBIC Venture Partners is located at Ottergemsesteenweg-Zuid 808 box 328, 9000 Gent.
Is QBIC Venture Partners still active?
Yes. According to the CBE (16 September 2026) QBIC Venture Partners is active, legal situation “Normale toestand”, started on 23 May 2012.
Is QBIC Venture Partners registered on Peppol?
Yes, QBIC Venture Partners is registered on the Peppol network with ID 0208:0846494353.
What is the enterprise number of QBIC Venture Partners?
The enterprise number of QBIC Venture Partners is BE0846494353.
When was QBIC Venture Partners founded?
QBIC Venture Partners was founded on 23 May 2012.
Who owns QBIC Venture Partners?
Behind QBIC Venture Partners are Danny Gonnissen BV, Loxus BV, Methexis Genomics NV, Innoconsult BV and Sophie Manigart. Danny Gonnissen BV is also behind Newton Biocapital I Investment Pool and Newton Biocapital II Partners. Methexis Genomics NV is also behind QBIC Partners. Innoconsult BV is also behind EVS BROADCAST EQUIPMENT, Faktion and VENTURE SPIRIT.